Literature DB >> 14100886

REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.

L HELLMAN, B ZUMOFF, G KESSLER, E KARA, I L RUBIN, R S ROSENFELD.   

Abstract

Entities:  

Keywords:  ANDROSTERONE; ASPARTATE AMINOTRANSFERASE; BLOOD ALKALINE PHOSPHATASE; BLOOD COAGULATION TESTS; BUTYRATES; GLYCERIDES; HYPERCHOLESTEREMIA; PHOSPHOLIPIDS; STEROLS; TOXICOLOGIC REPORT; URIC ACID

Mesh：

Substances：

Year:  1963        PMID： 14100886     DOI： 10.1016/s0368-1319(63)80025-3

Source DB:  PubMed          Journal:  J Atheroscler Res        ISSN： 0368-1319


× No keyword cloud information.
  5 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

Review 2.  Fibrates, glitazones, and peroxisome proliferator-activated receptors.

Authors:  Fanny Lalloyer; Bart Staels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05       Impact factor: 8.311

3.  Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.

Authors:  P Carson; L McDonald; S Pickard; T Pilkington; B Davies; F Love
Journal:  Br Heart J       Date:  1966-05

4.  Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.

Authors: 
Journal:  Br Med J       Date:  1971-12-25

5.  Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.

Authors:  P Cuchet; C Morrier; F Cand; C Keriel
Journal:  Lipids       Date:  1981-10       Impact factor: 1.880
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.